Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells
Authors:
- Raul G. CarliniRCRaul G. Carlini
- Adriana S. DussoADAdriana S. Dusso
- Chamberlain I. ObialoCOChamberlain I. Obialo
- Ulises M. AlvarezUAUlises M. Alvarez
- Marcos RothsteinMRMarcos Rothstein
- 1 May 1993
- journal article
- Published by Elsevier in Kidney International
- Vol. 43 (5) , 1010-1014
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisThe American Journal of Medicine, 1990
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Epoetin (Recombinant Human Erythropoietin)Drugs, 1989
- Correction of Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: Safety and Efficacy of One Year's Treatment in a European Multicentre Study of 150 Haemodialysis-Dependent Patients*Nephrology Dialysis Transplantation, 1989
- Rheology in Whole Blood and in Red Blood Cells under Recombinant Human Erythropoietin Therapy1989
- Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in JapanThe International Journal of Artificial Organs, 1988
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- Blood Pressure Changes during Treatment with Recombinant Human Erythropoietin1988